Literature DB >> 24781284

Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.

Joseph Kuchling1, Caren Ramien1, Ivan Bozin1, Jan Dörr2, Lutz Harms3, Berit Rosche3, Thoralf Niendorf4, Friedemann Paul5, Tim Sinnecker6, Jens Wuerfel7.   

Abstract

Potential differences between primary progressive (PP) and relapsing-remitting (RR) multiple sclerosis (MS) have been controversially discussed. In this study, we compared lesion morphology and distribution in patients with PPMS and RRMS (nine in each group) using 7 T MRI. We found that gray and white matter lesions in PPMS and RRMS patients did not differ in their respective morphological characteristics (e.g., perivascular p = 0.863, hypointense rim p = 0.796, cortical lesion count p = 0.436). Although limited by a small sample size, our study results suggest that PPMS and RRMS, despite differences in disease course and clinical characteristics, exhibit identical lesion morphology under ultrahigh field MRI.
© The Author(s), 2014.

Entities:  

Keywords:  7 T MRI; MRI; PPMS; RRMS; primary progressive multiple sclerosis; relapsing–remitting multiple sclerosis; ultrahigh field MRI

Mesh:

Year:  2014        PMID: 24781284     DOI: 10.1177/1352458514531084

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  19 in total

Review 1.  Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Authors:  Tim Sinnecker; Cristina Granziera; Jens Wuerfel; Regina Schlaeger
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

2.  SWAN-Venule: An Optimized MRI Technique to Detect the Central Vein Sign in MS Plaques.

Authors:  M I Gaitán; P Yañez; M E Paday Formenti; I Calandri; E Figueiredo; P Sati; J Correale
Journal:  AJNR Am J Neuroradiol       Date:  2020-02-13       Impact factor: 3.825

3.  Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.

Authors:  A Burgetova; P Dusek; M Vaneckova; D Horakova; C Langkammer; J Krasensky; L Sobisek; P Matras; M Masek; Z Seidl
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-27       Impact factor: 3.825

4.  Interleaved susceptibility-weighted and FLAIR MRI for imaging lesion-penetrating veins in multiple sclerosis.

Authors:  Refaat E Gabr; Amol S Pednekar; Arash Kamali; John A Lincoln; Flavia M Nelson; Jerry S Wolinsky; Ponnada A Narayana
Journal:  Magn Reson Med       Date:  2018-01-15       Impact factor: 4.668

Review 5.  Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Authors:  Ruth Geraldes; Margaret M Esiri; Gabriele C DeLuca; Jacqueline Palace
Journal:  Brain Pathol       Date:  2017-03-12       Impact factor: 6.508

Review 6.  The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.

Authors:  Pascal Sati; Jiwon Oh; R Todd Constable; Nikos Evangelou; Charles R G Guttmann; Roland G Henry; Eric C Klawiter; Caterina Mainero; Luca Massacesi; Henry McFarland; Flavia Nelson; Daniel Ontaneda; Alexander Rauscher; William D Rooney; Amal P R Samaraweera; Russell T Shinohara; Raymond A Sobel; Andrew J Solomon; Constantina A Treaba; Jens Wuerfel; Robert Zivadinov; Nancy L Sicotte; Daniel Pelletier; Daniel S Reich
Journal:  Nat Rev Neurol       Date:  2016-11-11       Impact factor: 42.937

7.  Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.

Authors:  Ivan Bozin; Yulin Ge; Joseph Kuchling; Petr Dusek; Sanjeev Chawla; Lutz Harms; Klemens Ruprecht; Thoralf Niendorf; Friedemann Paul; Ilya Kister; Tim Sinnecker; Jens Wuerfel
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 8.  Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.

Authors:  Friedemann Paul; Jens Wuerfel; Tim Sinnecker; Joseph Kuchling; Petr Dusek; Jan Dörr; Thoralf Niendorf
Journal:  EPMA J       Date:  2015-08-27       Impact factor: 6.543

9.  Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis.

Authors:  Laura E Jonkman; Diana M Rosenthal; Maria Pia Sormani; Laura Miles; Joseph Herbert; Robert I Grossman; Matilde Inglese
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

10.  Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.

Authors:  Asaff Harel; Antonia Ceccarelli; Colleen Farrell; Michelle Fabian; Jonathan Howard; Claire Riley; Aaron Miller; Fred Lublin; Matilde Inglese
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.